These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 20711704)

  • 1. The role of complement in AMD.
    Zipfel PF; Lauer N; Skerka C
    Adv Exp Med Biol; 2010; 703():9-24. PubMed ID: 20711704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement factor H related proteins (CFHRs).
    Skerka C; Chen Q; Fremeaux-Bacchi V; Roumenina LT
    Mol Immunol; 2013 Dec; 56(3):170-80. PubMed ID: 23830046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD).
    Fritsche LG; Lauer N; Hartmann A; Stippa S; Keilhauer CN; Oppermann M; Pandey MK; Köhl J; Zipfel PF; Weber BH; Skerka C
    Hum Mol Genet; 2010 Dec; 19(23):4694-704. PubMed ID: 20843825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.
    Abarrategui-Garrido C; Martínez-Barricarte R; López-Trascasa M; de Córdoba SR; Sánchez-Corral P
    Blood; 2009 Nov; 114(19):4261-71. PubMed ID: 19745068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement factor H related proteins in immune diseases.
    Skerka C; Zipfel PF
    Vaccine; 2008 Dec; 26 Suppl 8():I9-14. PubMed ID: 19388158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement factor H and the hemolytic uremic syndrome.
    Atkinson JP; Goodship TH
    J Exp Med; 2007 Jun; 204(6):1245-8. PubMed ID: 17548524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement dysregulation and disease: from genes and proteins to diagnostics and drugs.
    de Cordoba SR; Tortajada A; Harris CL; Morgan BP
    Immunobiology; 2012 Nov; 217(11):1034-46. PubMed ID: 22964229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy.
    Togarsimalemath SK; Sethi SK; Duggal R; Le Quintrec M; Jha P; Daniel R; Gonnet F; Bansal S; Roumenina LT; Fremeaux-Bacchi V; Kher V; Dragon-Durey MA
    Kidney Int; 2017 Oct; 92(4):876-887. PubMed ID: 28729035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration.
    Richards A; Kavanagh D; Atkinson JP
    Adv Immunol; 2007; 96():141-77. PubMed ID: 17981206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complement fitness factor H: role in human diseases and for immune escape of pathogens, like pneumococci.
    Zipfel PF; Hallström T; Hammerschmidt S; Skerka C
    Vaccine; 2008 Dec; 26 Suppl 8():I67-74. PubMed ID: 19388168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related macular degeneration and the role of the complement system.
    McHarg S; Clark SJ; Day AJ; Bishop PN
    Mol Immunol; 2015 Sep; 67(1):43-50. PubMed ID: 25804937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome.
    Zipfel PF; Edey M; Heinen S; Józsi M; Richter H; Misselwitz J; Hoppe B; Routledge D; Strain L; Hughes AE; Goodship JA; Licht C; Goodship TH; Skerka C
    PLoS Genet; 2007 Mar; 3(3):e41. PubMed ID: 17367211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina.
    Clark SJ; Perveen R; Hakobyan S; Morgan BP; Sim RB; Bishop PN; Day AJ
    J Biol Chem; 2010 Sep; 285(39):30192-202. PubMed ID: 20660596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H.
    de Córdoba SR; de Jorge EG
    Clin Exp Immunol; 2008 Jan; 151(1):1-13. PubMed ID: 18081690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of complement in physiology and pathology].
    Klaska I; Nowak JZ
    Postepy Hig Med Dosw (Online); 2007; 61():167-77. PubMed ID: 17410057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual roles of different redox forms of complement factor H in protecting against age related macular degeneration.
    Krilis M; Qi M; Qi J; Wong JWH; Guymer R; Liew G; Hunyor AP; Madigan M; McCluskey P; Weaver J; Krilis SA; Giannakopoulos B
    Free Radic Biol Med; 2018 Dec; 129():237-246. PubMed ID: 30253188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement and diseases: defective alternative pathway control results in kidney and eye diseases.
    Zipfel PF; Heinen S; Józsi M; Skerka C
    Mol Immunol; 2006 Jan; 43(1-2):97-106. PubMed ID: 16026839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited.
    Anderson DH; Radeke MJ; Gallo NB; Chapin EA; Johnson PT; Curletti CR; Hancox LS; Hu J; Ebright JN; Malek G; Hauser MA; Rickman CB; Bok D; Hageman GS; Johnson LV
    Prog Retin Eye Res; 2010 Mar; 29(2):95-112. PubMed ID: 19961953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of factor H-like protein 1 as the predominant complement regulator in Bruch's membrane: implications for age-related macular degeneration.
    Clark SJ; Schmidt CQ; White AM; Hakobyan S; Morgan BP; Bishop PN
    J Immunol; 2014 Nov; 193(10):4962-70. PubMed ID: 25305316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the alternative complement pathway in vitreous is controlled by genetics in age-related macular degeneration.
    Loyet KM; Deforge LE; Katschke KJ; Diehl L; Graham RR; Pao L; Sturgeon L; Lewin-Koh SC; Hollyfield JG; van Lookeren Campagne M
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6628-37. PubMed ID: 22930722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.